Cardiovascular Toxicities of CAR T-cell Therapy

[1] Perica K(2015)Adoptive T cell immunotherapy for cancer Rambam Maimonides Med J 6 e124-ee31

[2] Varela JC(2017)Cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukemia Crit Care Med 45 1590-1595

[3] Oelke M(2018)Cardiac profile of chimeric antigen receptor T cell therapy in children: a single-institution experience Biol Blood Marrow Transplant 24 3099-3108

[4] Schneck J(2019)Cardiovascular events among adults treated with chimeric antigen receptor T-cells (CAR-T) J Am Coll Cardiol 74 193-203

[5] Fitzgerald JC(2020)Cardiovascular effects of CAR T cell therapy: a retrospective study JACC CardioOncol 2 e001159-1690

[6] Weiss SL(2020)Impact of cytokine release syndrome on cardiac function following CD19 CAR-T cell therapy in children and young adults with hematological malignancies Journal for ImmunoTherapy of Cancer 8 1687-1223

[7] Maude SL(2020)Chimeric antigen receptor T-cell therapy–associated cardiomyopathy in patients with refractory or relapsed non-Hodgkin lymphoma Circulation 142 1215-763

[8] Barrett DM(1991)Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens J Clin Oncol 9 758-101

[9] Lacey SF(1981)Cardiotoxicity associated with high-dose cyclophosphamide therapy Arch Intern Med 141 2324709613480346-4023

[10] Melenhorst JJ(2013)Cyclophosphamide-induced cardiomyopathy: a case report, review, and recommendations for management J Investig Med High Impact Case Rep 1 92-448

[1] Perica K(2015)Adoptive T cell immunotherapy for cancer Rambam Maimonides Med J 6 e124-ee31

[2] Varela JC(2017)Cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukemia Crit Care Med 45 1590-1595

[3] Oelke M(2018)Cardiac profile of chimeric antigen receptor T cell therapy in children: a single-institution experience Biol Blood Marrow Transplant 24 3099-3108

[4] Schneck J(2019)Cardiovascular events among adults treated with chimeric antigen receptor T-cells (CAR-T) J Am Coll Cardiol 74 193-203

[5] Fitzgerald JC(2020)Cardiovascular effects of CAR T cell therapy: a retrospective study JACC CardioOncol 2 e001159-1690

[6] Weiss SL(2020)Impact of cytokine release syndrome on cardiac function following CD19 CAR-T cell therapy in children and young adults with hematological malignancies Journal for ImmunoTherapy of Cancer 8 1687-1223

[7] Maude SL(2020)Chimeric antigen receptor T-cell therapy–associated cardiomyopathy in patients with refractory or relapsed non-Hodgkin lymphoma Circulation 142 1215-763

[8] Barrett DM(1991)Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens J Clin Oncol 9 758-101

[9] Lacey SF(1981)Cardiotoxicity associated with high-dose cyclophosphamide therapy Arch Intern Med 141 2324709613480346-4023

[10] Melenhorst JJ(2013)Cyclophosphamide-induced cardiomyopathy: a case report, review, and recommendations for management J Investig Med High Impact Case Rep 1 92-448